Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America..
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has caused widespread morbidity and mortality since its onset in late 2019. Here, we demonstrate that prior infection with human cytomegalovirus (HCMV) substantially increases infection with SARS-CoV-2 in vitro. HCMV is a common herpesvirus carried by 40%-100% of the population, which can reactivate in the lung under inflammatory conditions, such as those resulting from SARS-CoV-2 infection. We show in both endothelial and epithelial cell types that HCMV infection upregulates ACE2, the SARS-CoV-2 cell entry receptor. These observations suggest that HCMV reactivation events in the lung of healthy HCMV carriers could exacerbate SARS-CoV-2 infection and subsequent COVID-19 symptoms. This effect could contribute to the disparity of disease severity seen in ethnic minorities and those with lower socioeconomic status, due to their higher CMV seroprevalence. Our results warrant further clinical investigation as to whether HCMV infection influences the pathogenesis of SARS-CoV-2.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:227 |
---|---|
Enthalten in: |
The Journal of infectious diseases - 227(2023), 4 vom: 14. Feb., Seite 543-553 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Perera, Marianne R [VerfasserIn] |
---|
Links: |
---|
Themen: |
ACE2 |
---|
Anmerkungen: |
Date Completed 16.02.2023 Date Revised 24.02.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/infdis/jiac452 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349218072 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349218072 | ||
003 | DE-627 | ||
005 | 20231226042112.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/infdis/jiac452 |2 doi | |
028 | 5 | 2 | |a pubmed24n1164.xml |
035 | |a (DE-627)NLM349218072 | ||
035 | |a (NLM)36408607 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Perera, Marianne R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.02.2023 | ||
500 | |a Date Revised 24.02.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. | ||
520 | |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has caused widespread morbidity and mortality since its onset in late 2019. Here, we demonstrate that prior infection with human cytomegalovirus (HCMV) substantially increases infection with SARS-CoV-2 in vitro. HCMV is a common herpesvirus carried by 40%-100% of the population, which can reactivate in the lung under inflammatory conditions, such as those resulting from SARS-CoV-2 infection. We show in both endothelial and epithelial cell types that HCMV infection upregulates ACE2, the SARS-CoV-2 cell entry receptor. These observations suggest that HCMV reactivation events in the lung of healthy HCMV carriers could exacerbate SARS-CoV-2 infection and subsequent COVID-19 symptoms. This effect could contribute to the disparity of disease severity seen in ethnic minorities and those with lower socioeconomic status, due to their higher CMV seroprevalence. Our results warrant further clinical investigation as to whether HCMV infection influences the pathogenesis of SARS-CoV-2 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a ACE2 | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a HCMV | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a coinfection | |
650 | 4 | |a human cytomegalovirus | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
650 | 7 | |a EC 3.4.15.1 |2 NLM | |
700 | 1 | |a Greenwood, Edward J D |e verfasserin |4 aut | |
700 | 1 | |a Crozier, Thomas W M |e verfasserin |4 aut | |
700 | 1 | |a Elder, Elizabeth G |e verfasserin |4 aut | |
700 | 1 | |a Schmitt, Janika |e verfasserin |4 aut | |
700 | 1 | |a Crump, Colin M |e verfasserin |4 aut | |
700 | 1 | |a Lehner, Paul J |e verfasserin |4 aut | |
700 | 1 | |a Wills, Mark R |e verfasserin |4 aut | |
700 | 1 | |a Sinclair, John H |e verfasserin |4 aut | |
700 | 0 | |a Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research COVID BioResource Collaboration |e verfasserin |4 aut | |
700 | 1 | |a Baker, Stephen |e investigator |4 oth | |
700 | 1 | |a Bradley, John |e investigator |4 oth | |
700 | 1 | |a Dougan, Gordon |e investigator |4 oth | |
700 | 1 | |a Hess, Christoph |e investigator |4 oth | |
700 | 1 | |a Goodfellow, Ian |e investigator |4 oth | |
700 | 1 | |a Gupta, Ravi |e investigator |4 oth | |
700 | 1 | |a Kingston, Nathalie |e investigator |4 oth | |
700 | 1 | |a Lehner, Paul J |e investigator |4 oth | |
700 | 1 | |a Lyons, Paul A |e investigator |4 oth | |
700 | 1 | |a Matheson, Nicholas J |e investigator |4 oth | |
700 | 1 | |a Owehand, Willem H |e investigator |4 oth | |
700 | 1 | |a Saunders, Caroline |e investigator |4 oth | |
700 | 1 | |a Smith, Kenneth G C |e investigator |4 oth | |
700 | 1 | |a Summers, Charlotte |e investigator |4 oth | |
700 | 1 | |a Thaventhiran, James E D |e investigator |4 oth | |
700 | 1 | |a Toshner, Mark |e investigator |4 oth | |
700 | 1 | |a Weekes, Michael P |e investigator |4 oth | |
700 | 1 | |a Bucke, Ashlea |e investigator |4 oth | |
700 | 1 | |a Calder, Jo |e investigator |4 oth | |
700 | 1 | |a Canna, Laura |e investigator |4 oth | |
700 | 1 | |a Domingo, Jason |e investigator |4 oth | |
700 | 1 | |a Elmer, Anne |e investigator |4 oth | |
700 | 1 | |a Fuller, Stewart |e investigator |4 oth | |
700 | 1 | |a Harris, Julie |e investigator |4 oth | |
700 | 1 | |a Hewitt, Sarah |e investigator |4 oth | |
700 | 1 | |a Kennet, Jane |e investigator |4 oth | |
700 | 1 | |a Jose, Sherly |e investigator |4 oth | |
700 | 1 | |a Kourampa, Jenny |e investigator |4 oth | |
700 | 1 | |a Meadows, Anne |e investigator |4 oth | |
700 | 1 | |a O'Brien, Criona |e investigator |4 oth | |
700 | 1 | |a Price, Jane |e investigator |4 oth | |
700 | 1 | |a Publico, Cherry |e investigator |4 oth | |
700 | 1 | |a Rastall, Rebecca |e investigator |4 oth | |
700 | 1 | |a Ribeiro, Carla |e investigator |4 oth | |
700 | 1 | |a Rowlands, Jane |e investigator |4 oth | |
700 | 1 | |a Ruffolo, Valentina |e investigator |4 oth | |
700 | 1 | |a Tordesillas, Hugo |e investigator |4 oth | |
700 | 1 | |a Bullman, Ben |e investigator |4 oth | |
700 | 1 | |a Dunmore, Benjamin J |e investigator |4 oth | |
700 | 1 | |a Fawke, Stuart |e investigator |4 oth | |
700 | 1 | |a Gräf, Stefan |e investigator |4 oth | |
700 | 1 | |a Hodgson, Josh |e investigator |4 oth | |
700 | 1 | |a Huang, Christopher |e investigator |4 oth | |
700 | 1 | |a Hunter, Kelvin |e investigator |4 oth | |
700 | 1 | |a Jones, Emma |e investigator |4 oth | |
700 | 1 | |a Legchenko, Ekaterina |e investigator |4 oth | |
700 | 1 | |a Matara, Cecilia |e investigator |4 oth | |
700 | 1 | |a Martin, Jennifer |e investigator |4 oth | |
700 | 1 | |a O'Donnell, Ciara |e investigator |4 oth | |
700 | 1 | |a Pointon, Linda |e investigator |4 oth | |
700 | 1 | |a Pond, Nicole |e investigator |4 oth | |
700 | 1 | |a Shih, Joy |e investigator |4 oth | |
700 | 1 | |a Sutcliffe, Rachel |e investigator |4 oth | |
700 | 1 | |a Tilly, Tobias |e investigator |4 oth | |
700 | 1 | |a Treacy, Carmen |e investigator |4 oth | |
700 | 1 | |a Tong, Zhen |e investigator |4 oth | |
700 | 1 | |a Wood, Jennifer |e investigator |4 oth | |
700 | 1 | |a Wylot, Marta |e investigator |4 oth | |
700 | 1 | |a Bergamaschi, Laura |e investigator |4 oth | |
700 | 1 | |a Betancourt, Ariana |e investigator |4 oth | |
700 | 1 | |a Bower, Georgie |e investigator |4 oth | |
700 | 1 | |a De Sa, Aloka |e investigator |4 oth | |
700 | 1 | |a Epping, Madeline |e investigator |4 oth | |
700 | 1 | |a Fawke, Stuart |e investigator |4 oth | |
700 | 1 | |a Huhn, Oisin |e investigator |4 oth | |
700 | 1 | |a Jackson, Sarah |e investigator |4 oth | |
700 | 1 | |a Jarvis, Isobel |e investigator |4 oth | |
700 | 1 | |a Marsden, Jimmy |e investigator |4 oth | |
700 | 1 | |a Nice, Francesca |e investigator |4 oth | |
700 | 1 | |a Okecha, Georgina |e investigator |4 oth | |
700 | 1 | |a Omarjee, Ommar |e investigator |4 oth | |
700 | 1 | |a Perera, Marianne |e investigator |4 oth | |
700 | 1 | |a Richoz, Nathan |e investigator |4 oth | |
700 | 1 | |a Sharma, Rahul |e investigator |4 oth | |
700 | 1 | |a Turner, Lori |e investigator |4 oth | |
700 | 1 | |a De Bie, Eckart M D D |e investigator |4 oth | |
700 | 1 | |a Bunclark, Katherine |e investigator |4 oth | |
700 | 1 | |a Josipovic, Masa |e investigator |4 oth | |
700 | 1 | |a Mackay, Michael |e investigator |4 oth | |
700 | 1 | |a Mescia, Federica |e investigator |4 oth | |
700 | 1 | |a Michael, Alice |e investigator |4 oth | |
700 | 1 | |a Rossi, Sabrina |e investigator |4 oth | |
700 | 1 | |a Selvan, Mayurun |e investigator |4 oth | |
700 | 1 | |a Spencer, Sarah |e investigator |4 oth | |
700 | 1 | |a Yong, Cissy |e investigator |4 oth | |
700 | 1 | |a Ansaripour, Ali |e investigator |4 oth | |
700 | 1 | |a Michael, Alice |e investigator |4 oth | |
700 | 1 | |a Mwaura, Lucy |e investigator |4 oth | |
700 | 1 | |a Patterson, Caroline |e investigator |4 oth | |
700 | 1 | |a Polwarth, Gary |e investigator |4 oth | |
700 | 1 | |a Polgarova, Petra |e investigator |4 oth | |
700 | 1 | |a di Stefano, Giovanni |e investigator |4 oth | |
700 | 1 | |a Allison, John |e investigator |4 oth | |
700 | 1 | |a Biggs, Heather |e investigator |4 oth | |
700 | 1 | |a Butcher, Helen |e investigator |4 oth | |
700 | 1 | |a Caputo, Daniela |e investigator |4 oth | |
700 | 1 | |a Chandler, Matt |e investigator |4 oth | |
700 | 1 | |a Chinnery, Patrick F |e investigator |4 oth | |
700 | 1 | |a Clapham-Riley, Debbie |e investigator |4 oth | |
700 | 1 | |a Dean, Anne-Maree |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 227(2023), 4 vom: 14. Feb., Seite 543-553 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
773 | 1 | 8 | |g volume:227 |g year:2023 |g number:4 |g day:14 |g month:02 |g pages:543-553 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiac452 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 227 |j 2023 |e 4 |b 14 |c 02 |h 543-553 |